Loading...
Header Logo
Keywords
Last Name
Institution

Mark Wolraich

TitleProf
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentDept of Pediatrics
Address274 NE 14th St
Oklahoma City OK 73104-0001
Phone405/271-5700
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    T32HD007285     (WOLRAICH, MARK L)Sep 30, 1986 - Jun 30, 1992
    NIH/NICHD
    RESEARCH TRAINING PROGRAM IN BEHAVIORAL PEDIATRICS
    Role: Principal Investigator

    R01MH040875     (WOLRAICH, MARK L)Apr 1, 1987 - May 31, 1990
    NIH/NIMH
    ROLE OF PRIMARY CARE PHYSICIANS IN CHILDREN WITH ADD
    Role: Principal Investigator

    R01HD024751     (WOLRAICH, MARK L)Aug 1, 1988 - Apr 30, 1992
    NIH/NICHD
    COGNITIVE EFFECTS OF SUGAR DIETS ON CHILDREN
    Role: Principal Investigator

    R01MH059461     (BICKMAN, LEONARD)Aug 1, 1998 - Jun 30, 2003
    NIH/NIMH
    ENHANCING ADHD RX EFFECTIVENESS BY PEDIATRICS &SCHOOLS
    Role: Co-Principal Investigator

    U50DD622315     (WOLRAICH, MARK L)Sep 30, 2002 - Sep 29, 2007
    CDC/NCBDD
    Population-Based Research in Attention-Deficit Hyperactivity Disorder
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wolraich ML. An Association Between Prenatal Acetaminophen Use and ADHD: The Benefits of Large Data Sets. Pediatrics. 2017 11; 140(5). PMID: 29084834.
      View in: PubMed
    2. Wolraich ML. It Takes a Full-Service Village to Treat Children With ADHD. Pediatrics. 2016 12; 138(6). PMID: 27940729.
      View in: PubMed
    3. Visser SN, Danielson ML, Wolraich ML, Fox MH, Grosse SD, Valle LA, Holbrook JR, Claussen AH, Peacock G. Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014. MMWR Morb Mortal Wkly Rep. 2016 May 06; 65(17):443-50. PMID: 27149047.
      View in: PubMed
    4. Wolraich ML. The frontiers of research about attention-deficit/hyperactivity disorder. Pediatrics. 2015 Apr; 135(4):e1042-3. PMID: 25802353.
      View in: PubMed
    5. Visser SN, Bitsko RH, Danielson ML, Ghandour RM, Blumberg SJ, Schieve LA, Holbrook JR, Wolraich ML, Cuffe SP. Treatment of Attention Deficit/Hyperactivity Disorder among Children with Special Health Care Needs. J Pediatr. 2015 Jun; 166(6):1423-30.e1-2. PMID: 25841538; PMCID: PMC4469986.
    6. Butcher JS, Wolraich ML, Gillaspy SR, Martin VG, Wild RC. The impact of a Medical Home for children with developmental disability within a pediatric resident continuity clinic. . J Okla State Med Assoc. 2014 Dec; 107(12):632-8. PMID: 25790586.
      View in: PubMed
    7. McKeown RE, Holbrook JR, Danielson ML, Cuffe SP, Wolraich ML, Visser SN. The impact of case definition on attention-deficit/hyperactivity disorder prevalence estimates in community-based samples of school-aged children. J Am Acad Child Adolesc Psychiatry. 2015 Jan; 54(1):53-61. PMID: 25524790; PMCID: PMC4472453.
    8. Hamilton DR, Stein MT, Wolraich M. Doctor-patient/family relationships: current status and projections for the future. J Dev Behav Pediatr. 2014 Sep; 35(7):443-5. PMID: 25119495.
      View in: PubMed
    9. Woods D, Wolraich M, Pierce K, DiMarco L, Muller N, Sachdeva R. Considerations and evidence for an ADHD outcome measure. Acad Pediatr. 2014 Sep-Oct; 14(5 Suppl):S54-60. PMID: 25169459.
      View in: PubMed
    10. Blucker RT, Jackson D, Gillaspy JA, Hale J, Wolraich M, Gillaspy SR. Pediatric behavioral health screening in primary care: a preliminary analysis of the pediatric symptom checklist-17 with functional impairment items. Clin Pediatr (Phila). 2014 May; 53(5):449-55. PMID: 24647696.
      View in: PubMed
    11. Wolraich M, Lockhart J, Worley L. An innovative Oklahoma program to coordinate interdisciplinary and interagency services for children with special healthcare needs at a county level. J Okla State Med Assoc. 2013 Mar; 106(3):90-4. PMID: 23687718.
      View in: PubMed
    12. Bard DE, Wolraich ML, Neas B, Doffing M, Beck L. The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic parent rating scale in a community population. J Dev Behav Pediatr. 2013 Feb; 34(2):72-82. PMID: 23363972.
      View in: PubMed
    13. Wolraich ML, Bard DE, Neas B, Doffing M, Beck L. The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic teacher rating scale in a community population. J Dev Behav Pediatr. 2013 Feb; 34(2):83-93. PMID: 23363973.
      View in: PubMed
    14. Wolraich ML, McKeown RE, Visser SN, Bard D, Cuffe S, Neas B, Geryk LL, Doffing M, Bottai M, Abramowitz AJ, Beck L, Holbrook JR, Danielson M. The prevalence of ADHD: its diagnosis and treatment in four school districts across two states. J Atten Disord. 2014 Oct; 18(7):563-75. PMID: 22956714.
      View in: PubMed
    15. Wolraich ML. The new attention deficit hyperactivity disorder clinical practice guidelines published by the American Academy of Pediatrics. J Dev Behav Pediatr. 2012 Jan; 33(1):76-7. PMID: 22218017.
      View in: PubMed
    16. Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, Meyer B, Perrin J, Pierce K, Reiff M, Stein MT, Visser S. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011 Nov; 128(5):1007-22. PMID: 22003063; PMCID: PMC4500647.
    17. Stein MT, Gottsegen D, Blasco PA, Wolraich M, Hennessy MJ. Chronic hip pain in a boy with mental retardation and cerebral palsy. J Dev Behav Pediatr. 2010 Apr; 31(3 Suppl):S86-91. PMID: 20414086.
      View in: PubMed
    18. Wolraich ML, Bard DE, Stein MT, Rushton JL, O'Connor KG. Pediatricians' attitudes and practices on ADHD before and after the development of ADHD pediatric practice guidelines. J Atten Disord. 2010 May; 13(6):563-72. PMID: 19706877.
      View in: PubMed
    19. Wolraich ML. Attention-deficit/hyperactivity disorder. Pediatr Ann. 2008 Jan; 37(1):7-8. PMID: 18240847.
      View in: PubMed
    20. Leslie LK, Wolraich ML. ADHD service use patterns in youth. J Pediatr Psychol. 2007 Jul; 32(6):695-710. PMID: 17556401.
      View in: PubMed
    21. Wigal SB, Wilens TE, Wolraich M, Lerner M. Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study results. Pediatrics. 2007 Jul; 120(1):e120-8. PMID: 17548486.
      View in: PubMed
    22. Wolraich ML. Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD. Evid Based Ment Health. 2007 May; 10(2):60. PMID: 17459991.
      View in: PubMed
    23. Wolraich ML, McGuinn L, Doffing M. Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations. Drug Saf. 2007; 30(1):17-26. PMID: 17194168.
      View in: PubMed
    24. Leslie LK, Wolraich ML. ADHD service use patterns in youth. Ambul Pediatr. 2007 Jan-Feb; 7(1 Suppl):107-20. PMID: 17261490.
      View in: PubMed
    25. Wolraich ML. Attention-deficit hyperactivity disorder. Semin Pediatr Neurol. 2006 Dec; 13(4):279-85. PMID: 17178358.
      View in: PubMed
    26. Wolraich ML. Stimulant medications and their adverse events and the food and drug administration: what can we conclude? J Dev Behav Pediatr. 2006 Apr; 27(2):177-8. PMID: 16682885.
      View in: PubMed
    27. Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2005 Oct; 44(10):1015-23. PMID: 16175106.
      View in: PubMed
    28. Wolraich ML, Bickman L, Lambert EW, Simmons T, Doffing MA. Intervening to improve communication between parents, teachers, and primary care providers of children with ADHD or at high risk for ADHD. J Atten Disord. 2005 Aug; 9(1):354-68. PMID: 16371681.
      View in: PubMed
    29. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics. 2005 Jun; 115(6):e749-57. PMID: 15930203.
      View in: PubMed
    30. Wolraich ML, Wibbelsman CJ, Brown TE, Evans SW, Gotlieb EM, Knight JR, Ross EC, Shubiner HH, Wender EH, Wilens T. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005 Jun; 115(6):1734-46. PMID: 15930238.
      View in: PubMed
    31. Stein MT, Gottsegen D, Blasco PA, Wolraich M, Hennessy M. Chronic hip pain in a boy with mental retardation and cerebral palsy. J Dev Behav Pediatr. 2005 Apr; 26(2):152-7. PMID: 15827468.
      View in: PubMed
    32. Wolraich ML. Review: relying on published data alone overestimates efficacy and safety of SSRIs in children. Evid Based Ment Health. 2004 Nov; 7(4):115. PMID: 15504803.
      View in: PubMed
    33. Wolraich ML, Lambert EW, Bickman L, Simmons T, Doffing MA, Worley KA. Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2004 Feb; 25(1):41-7. PMID: 14767355.
      View in: PubMed
    34. Wolraich ML, Doffing MA. Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate. CNS Drugs. 2004; 18(4):243-50. PMID: 15015904.
      View in: PubMed
    35. Derivan AT, Leventhal BL, March J, Wolraich M, Zito JM. The ethical use of placebo in clinical trials involving children. J Child Adolesc Psychopharmacol. 2004; 14(2):169-74. PMID: 15319014.
      View in: PubMed
    36. Wolraich ML, Lambert W, Doffing MA, Bickman L, Simmons T, Worley K. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol. 2003 Dec; 28(8):559-67. PMID: 14602846.
      View in: PubMed
    37. Wolraich ML, Lambert EW, Baumgaertel A, Garcia-Tornel S, Feurer ID, Bickman L, Doffing MA. Teachers' screening for attention deficit/hyperactivity disorder: comparing multinational samples on teacher ratings of ADHD. J Abnorm Child Psychol. 2003 Aug; 31(4):445-55. PMID: 12831232.
      View in: PubMed
    38. Wolraich ML, Bennett FC. History of developmental-behavioral pediatrics. J Dev Behav Pediatr. 2003 Jun; 24(3):215-6; author reply 216. PMID: 12806234.
      View in: PubMed
    39. Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003 Apr; 42(4):424-33. PMID: 12649629.
      View in: PubMed
    40. Wolraich ML. Annotation: The use of psychotropic medications in children: an American view. J Child Psychol Psychiatry. 2003 Feb; 44(2):159-68. PMID: 12587853.
      View in: PubMed
    41. Wolraich ML. Attention-deficit/hyperactivity disorder: issues for the pediatric office. Pediatr Ann. 2002 Aug; 31(8):469-70. PMID: 12174761.
      View in: PubMed
    Wolraich's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description